Kurs
-7,44%
Likviditet
4,24 MSEK
Prenumeration
Kalender
Est. tid* | ||
2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-10 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-07-07 | N/A | X-dag ordinarie utdelning ATORX 0.00 SEK |
2025-05-07 | - | Årsstämma |
2025-04-24 | - | Kvartalsrapport 2025-Q1 |
2025-04-07 | - | Split ATORX 1000:1 |
2025-03-27 | - | Extra Bolagsstämma 2024 |
2025-01-22 | - | Bokslutskommuniké 2024 |
2024-10-24 | - | Kvartalsrapport 2024-Q3 |
2024-07-11 | - | Kvartalsrapport 2024-Q2 |
2024-05-08 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2024-05-07 | - | Årsstämma |
2024-05-06 | - | Kvartalsrapport 2024-Q1 |
2024-02-09 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-13 | - | Kvartalsrapport 2023-Q2 |
2023-05-26 | - | Årsstämma |
2023-05-04 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2023-04-25 | - | Kvartalsrapport 2023-Q1 |
2023-04-14 | - | Extra Bolagsstämma 2022 |
2023-02-10 | - | Bokslutskommuniké 2022 |
2022-10-20 | - | Kvartalsrapport 2022-Q3 |
2022-07-12 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-11 | - | Bokslutskommuniké 2021 |
2021-11-08 | - | Extra Bolagsstämma 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-07-13 | - | Kvartalsrapport 2021-Q2 |
2021-06-01 | - | Årsstämma |
2021-05-03 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2021-04-27 | - | Kvartalsrapport 2021-Q1 |
2021-02-26 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-13 | - | Kvartalsrapport 2020-Q2 |
2020-05-06 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2020-05-05 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-12 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-07-11 | - | Kvartalsrapport 2019-Q2 |
2019-05-10 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2019-05-09 | - | Årsstämma |
2019-04-17 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-10-26 | - | Kvartalsrapport 2018-Q3 |
2018-07-12 | - | Kvartalsrapport 2018-Q2 |
2018-04-27 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2018-04-26 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-10-25 | - | Kvartalsrapport 2017-Q3 |
2017-08-23 | - | Kvartalsrapport 2017-Q2 |
2017-05-03 | - | X-dag ordinarie utdelning ATORX 0.00 SEK |
2017-05-02 | - | Årsstämma |
2017-05-02 | - | Kvartalsrapport 2017-Q1 |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-11-14 | - | Kvartalsrapport 2016-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
During June 2025, the number of shares and votes in Alligator Bioscience AB (“Alligator Bioscience”) has increased as a result of the exercise of warrants series TO 12, issued in connection with the rights issue of units carried out during December 2024 – February 2025 (the “Warrant Programme”), as well as the directed new share issues of ordinary shares to guarantors in the Warrant Programme, which were resolved by the Board of Directors on 26 May 2025, based on the authorization granted by the annual general meeting on 7 May 2025.
As of 30 June 2025, the total number of shares and votes in Alligator Bioscience amounts to 34,803,898, of which all outstanding shares are ordinary shares with one vote each.
For further information, please contact:
Søren Bregenholt, CEO
E-mail: soren.bregenholt@alligatorbioscience.com
Phone: +46 (0) 46 540 82 00
This information is information that Alligator Bioscience is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-06-30 15:00 CEST.